Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Recruiting Phase 1Phase 2 Interventional

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

ClinicalTrials.gov ID: NCT06121297

Public ClinicalTrials.gov record NCT06121297. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Oct 20, 2026, 11:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1/2, Open-label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T Cells (CABA-201) in Subjects With Active Systemic Lupus Erythematosus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Study identification

NCT ID
NCT06121297
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Cabaletta Bio
Industry
Enrollment
28 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
12 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 16, 2024 (Actual)
Primary completion
Dec 2029 (Estimated)
Completion
Dec 2029 (Estimated)
Last update posted
Oct 6, 2026

2024 – 2029

United States locations

U.S. sites
21
U.S. states
13
U.S. cities
17
Facility City State ZIP Site status
University of California Irvine Orange California 92868 Recruiting
UC Davis Health Sacramento California 95817 Recruiting
Yale University New Haven Connecticut 06520 Terminated
University of Florida Health Gainesville Florida 32610 Active, not recruiting
Mayo Clinic Jacksonville Florida 32224 Recruiting
Emory University Atlanta Georgia 30322 Recruiting
Northwestern Memorial Hospital Chicago Illinois 60611 Recruiting
The University of Chicago Medical Center - Accepting Adult and Adolescent Patients Chicago Illinois 60637 Recruiting
University of Kansas Medical Center Kansas City Kansas 66160 Recruiting
Tufts Medical Center Boston Massachusetts 02111 Recruiting
Massachusetts General Hospital Boston Massachusetts 02114 Recruiting
Boston Children's Hospital - Accepting Young Adult and Adolescent Patients Boston Massachusetts 02115 Recruiting
Brigham and Women's Hospital Boston Massachusetts 02115 Recruiting
UMass Memorial Hospital Worcester Massachusetts 01655 Recruiting
University of Minnesota Minneapolis Minnesota 55414 Recruiting
Columbia University Irving Medical Center New York New York 10032 Withdrawn
University of Rochester Rochester New York 14642 Recruiting
UNC Chapel Hill Chapel Hill North Carolina 27599 Recruiting
Children's Hospital of Philadelphia - Accepting Young Adult and Adolescent Patients Philadelphia Pennsylvania 19104 Recruiting
Medical University of South Carolina Charleston South Carolina 29425 Recruiting
University of Texas MD Anderson Cancer Center Houston Texas 77030 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06121297, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 6, 2026 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06121297 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →